Examkin

Soru

Zorluk: ZorPreventive Care and Screening

A 70-year-old male presents to the clinic to establish primary care. He has not seen a physician in over a decade. His past medical history is significant for severe chronic obstructive pulmonary disease (COPD) requiring continuous home oxygen therapy (FEV1 32% of predicted), and ischemic cardiomyopathy with a left ventricular ejection fraction of 25% and NYHA Class III symptoms. He reports being housebound due to dyspnea on minimal exertion. He currently feels at his baseline and denies abdominal pain, changes in bowel habits, or rectal bleeding. A complete blood count reveals a hemoglobin of 14.5 g/dL. He has never undergone colorectal cancer screening but asks if he should be tested now because a close friend was recently diagnosed with colon polyps. Which of the following is the most appropriate next step regarding colorectal cancer screening for this patient?

  1. A
    Refer the patient for a screening colonoscopy
  2. B
    Order an annual fecal immunochemical test
  3. Advise the patient that screening is not indicatedCevap
  4. D
    Refer the patient for a screening CT colonography
  5. E
    Order a multi-target stool DNA test

Cevap

Advise the patient that screening is not indicated due to his severe, life-limiting comorbidities and limited life expectancy.
Colorectal cancer screening is generally recommended for adults aged 45 to 75. However, major medical societies explicitly emphasize that screening should be individualized. It is most appropriate for adults who are healthy enough to undergo treatment if cancer is detected and who do not have life-limiting comorbid conditions. This patient has severe, end-stage cardiopulmonary disease (oxygen-dependent COPD and NYHA Class III heart failure). His life expectancy is severely limited (well under 10 years), meaning he will not realize the long-term mortality benefits of detecting a slow-growing cancer. Furthermore, the procedural risks of colonoscopy (sedation-related respiratory failure or hemodynamic collapse) vastly outweigh the benefits. Because he cannot safely undergo a colonoscopy, even non-invasive initial screening tests are inappropriate, as a positive result cannot be safely evaluated. Therefore, the most appropriate step is to advise against screening.

Adım Adım Çözüm

1
Evaluate the patient's age and general screening indication.
The patient is 70 years old, which falls within the standard age range (45-75 years) for routine colorectal cancer screening.
Age is the primary determinant for initiating routine population-based screening.
2
Assess the patient's overall health status and life expectancy.
The patient has oxygen-dependent COPD and NYHA Class III ischemic cardiomyopathy, significantly limiting his life expectancy to less than 10 years.
Preventive screening requires a sufficient life expectancy (typically > 10 years) for the patient to realize a mortality benefit from the detection and treatment of early-stage cancer.
3
Evaluate the risks associated with the screening pathway.
Diagnostic colonoscopy would carry an unacceptably high risk of sedation-related cardiopulmonary collapse.
If a non-invasive test (like a fecal immunochemical test) is positive, a colonoscopy is mandatory. You cannot safely complete the screening cascade.
4
Determine the most appropriate management plan.
Discontinue or advise against screening through shared decision-making.
When procedural risks outweigh theoretical benefits and life expectancy is short, withholding screening is the standard of care.

Anahtar Kavram

Individualization of cancer screening based on life expectancy and comorbidities.
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru